1 Min Read
Oct 3 (Reuters) - Collegium Pharmaceutical Inc :
* Co announced submission of a new drug submission to Health Canada seeking marketing approval of Xtampza() ER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.